436PEfficacy and safety of necitumumab (neci) in East Asian (EA) patients (pts) with stage IV squamous non-small-cell lung cancer (NSCLC): a subanalysis of the SQUIRE trial:
Park, K., Cho, E.K., Bello, M., Ahn, M.-J., Thongprasert, S., Song, E.-K., Soldatenkova, V., Depenbrock, H., Puri, T., Orlando, M.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv532.20
Date:
December, 2015
File:
PDF, 42 KB
english, 2015